Guilin Sanjin(SZ:002275)2025-06-27 10:10Financial Performance - In 2024, the company achieved total revenue of 2,193.99 million CNY, a growth of 1.03% compared to 2023's 2,171.60 million CNY [1] - The total profit reached 643.94 million CNY, an increase of 24.24% from 518.28 million CNY in the previous year [1] - The net profit attributable to shareholders was 521.53 million CNY, up 23.79% from 421.30 million CNY year-on-year [1] - In Q1 2025, the net profit after deducting non-recurring gains and losses was 97.67 million CNY, reflecting an 11.61% increase from 87.52 million CNY in Q1 2024 [1] Product Development - The company’s second and third-tier products are showing a positive development trend, with continued support from the company [1] - The sales of the "Xuan Yun Ning" series surpassed 100 million CNY in 2021, with a goal of achieving double-digit growth this year [1] - The company aims for "La Mo San Zhi Pian" to reach the 100 million CNY milestone this year, while other products like "Shu Yan Qing" spray and "Fu Fang Gan Mao Ling" granules are expected to maintain high growth rates [1] - Although second and third-tier products lag behind first-tier in absolute volume, their growth rate is better overall [1] Biopharmaceutical Sector - Biopharmaceuticals are a key part of the company's dual strategy, facing a long R&D cycle and high investment risks [2] - The company is experiencing a challenging environment in the biopharmaceutical sector, with increased competition and diverse customer choices [2] - The company is optimizing its R&D pipeline, focusing on projects with promising clinical data, such as the BC006 monoclonal injection, which is nearing completion of Phase I clinical trials [2] Dividend and Employee Incentives - The company is committed to providing stable returns to investors, maintaining a cash dividend policy since its listing [2] - For 2024, the proposed dividend is 3.5 CNY per 10 shares, totaling 206 million CNY in cash dividends [2] - The first phase of the employee stock ownership plan has improved employee cohesion and competitiveness, with plans to refine performance evaluation mechanisms for future incentive programs [2]